BRUXISM TREATMENT MARKET ANALYSIS
Global Bruxism Treatment Market: Key Developments
On October 7, 2022, Desktop Health, a healthcare business within Desktop Metal, Inc., a company focused on developing 3D printing solutions for personalized medicine, announced that it had received the U.S. Food and Drug Administration (FDA) 510(k) clearance of SmileGuard resin, a light, biocompatible material for the fabrication of strong & flexible bite splints and other orthodontic and dental appliances.
On November 17, 2022, RespireRx Pharmaceuticals Inc., a pharmaceutical company, announced that on November 14, 2022, the company entered into a letter of intent (LOI) with an Australia headquartered, bespoke clinical research organization focused on cannabinoid and psychedelic clinical research. Under the contract, the CRO (clinical research organization) is expected to provide full service CRO services, including regulatory, compliance, and GMP (good manufacturing practices) manufacturing services in addition to human pharmacokinetic and pivotal human efficacy and safety studies of dronabinol for the treatment of obstructive sleep apnea.
On June 23, 2022, Yenepoya (Deemed to be University), Karnataka, India and DentCare Dental Lab Pvt. Ltd, Muvattupuzha, in Kerala, India signed a memorandum of understanding (MoU). Yenepoya is taking a major step towards providing an opportunity to aspiring candidates intending to make a career in dental technology.
Bruxism Treatment Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :